Showing results (131-140 of 355) with videos related to

Sort By:
Pageof 36
Contrast Media & Molecular Imaging|February 18, 2020
Radiolabeled Cationic Peptides for Targeted Imaging of InfectionTolulope A Aweda, Zumrut F B Muftuler, Adriana V F Massicano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2025
Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast CancerShannon E Lynch, Corinne Crawford, Addison L Hunt, et al.
Scientific Reports|April 2, 2025
PET imaging of differentiated thyroid cancer with thyrotropin-alfaGrayson R Gimblet, Pratheek Reddy, Michelle M Holland, et al.
Molecular Pharmaceutics|July 8, 2024
PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [89Zr]Zr-TR1402Grayson R Gimblet, Hailey A Houson, Jason Whitt, et al.
Frontiers in Immunology|December 19, 2024
SON-1010: an albumin-binding IL-12 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacyJohn K Cini, Richard T Kenney, Susan Dexter, et al.
Nuclear Medicine and Biology|November 6, 2012
Enhanced radiosyntheses of [¹¹C]raclopride and [¹¹C]DASB using ethanolic loop chemistryXia Shao, Paul L Schnau, Maria V Fawaz, et al.
Journal of Nuclear Medicine Technology|November 9, 2022
SNMMI Clinical Trial Network Research Series for Technologists: Application of Good Clinical Practice to Clinical Research in Medical ImagingLisaAnn Trembath, Sarah A Frye, Peter J H Scott, et al.
Journal of Nuclear Medicine Technology|September 5, 2024
SNMMI Clinical Trials Network Research Series for Technologists: An Introduction to Conducting Theranostic Clinical TrialsFreddy Gonzalez, Peter J H Scott, Charlotte Denise Jeffers, et al.
Surgery|October 21, 2019
Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatmentRachael Guenter, Tolulope Aweda, Danilea M Carmona Matos, et al.
Pageof 36